Page last updated: 2024-10-24

chlorambucil and Hemoptysis

chlorambucil has been researched along with Hemoptysis in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Hemoptysis: Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zimmerman, RA1
Miller, WT1

Other Studies

1 other study available for chlorambucil and Hemoptysis

ArticleYear
Pulmonary aspergillosis.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1970, Volume: 109, Issue:3

    Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Chlorambucil; Dyspnea; Female; Hemoptysis; Humans;

1970